Haemodialysis efficiency after long-term treatment with recombinant human erythropoietin.


In 11 chronic haemodialysis patients we investigated whether the increase in haematocrit during recombinant human erythropoietin (rHuEPO) treatment might alter the long-term efficiency of haemodialysis. After correction of anaemia with rHuEPO (mean Ht 35 +/- 2% vs 19 +/- 2% at baseline) (p 0.001), mean predialysis creatinine and urea did not change, while… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.